These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33950028)

  • 1. Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied Manifestation.
    Peleg Hasson S; Arnold J; Merdler I; Sivan A; Shamai S; Geva R; Merimsky O; Shachar E; Waissengrin B; Moshkovits Y; Arbel Y; Topilsky Y; Rozenbaum Z; Wolf I; Laufer-Perl M
    J Immunother; 2021 Jun; 44(5):179-184. PubMed ID: 33950028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early evaluation of subclinical cardiotoxicity in patients with lung cancer receiving immune checkpoint inhibitors by cardiovascular magnetic resonance: a prospective observational study.
    Liu J; Cao Y; Zhu K; Yao S; Yuan M; Kong X; Liu X; Li Y; Cui Y; Han X; Zhou X; Meng R; Shi H
    Quant Imaging Med Surg; 2022 Oct; 12(10):4771-4785. PubMed ID: 36185042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Therapeutics-Related Cardiac Dysfunction among Patients with Active Breast Cancer: A Cardio-Oncology Registry.
    Laufer-Perl M; Mor L; Milwidsky A; Derakhshesh M; Amrami N; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Rozenbaum Z
    Isr Med Assoc J; 2020 Sep; 22(9):564-568. PubMed ID: 33236555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-toxicity among patients with sarcoma: a cardio-oncology registry.
    Shamai S; Rozenbaum Z; Merimsky O; Derakhshesh M; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Laufer-Perl M
    BMC Cancer; 2020 Jun; 20(1):609. PubMed ID: 32605637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin.
    Lee SH; Cho I; You SC; Cha MJ; Chang JS; Kim WD; Go KY; Kim DY; Seo J; Shim CY; Hong GR; Kang SM; Ha JW; Rha SY; Kim HS
    Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity of Immune Checkpoint Inhibitors.
    Patel RP; Parikh R; Gunturu KS; Tariq RZ; Dani SS; Ganatra S; Nohria A
    Curr Oncol Rep; 2021 May; 23(7):79. PubMed ID: 33937956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
    Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors.
    Mladosievičová B; Országhová Z; Jablonická M; Rečková M; Chovanec M; Mego M
    Klin Onkol; 2020; 33(5):350-355. PubMed ID: 33108879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of adverse cardiovascular events associated with immune checkpoint inhibitors and risk factors for left ventricular dysfunction: A single-center prospective clinical study.
    Zhang C; Chen Z; Qin S; Zhu Y; Shu L; Zuo Z
    Front Cardiovasc Med; 2023; 10():1052699. PubMed ID: 36755798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of reduced global longitudinal strain with cancer therapy-related cardiac dysfunction among patients receiving cancer therapy.
    Laufer-Perl M; Arnold JH; Mor L; Amrami N; Derakhshesh M; Moshkovits Y; Sadeh B; Arbel Y; Topilsky Y; Rozenbaum Z
    Clin Res Cardiol; 2020 Feb; 109(2):255-262. PubMed ID: 31214777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation recovery interval as an electrocardiographic repolarization index to detect doxorubicin-induced cardiotoxicity.
    Kinoshita T; Onda N; Ohno R; Ikeda T; Sugizaki Y; Ohara H; Nakagami T; Yuzawa H; Shimada H; Shimizu K; Ikeda T
    J Cardiol; 2023 Dec; 82(6):473-480. PubMed ID: 37506822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.
    Oikonomou EK; Kokkinidis DG; Kampaktsis PN; Amir EA; Marwick TH; Gupta D; Thavendiranathan P
    JAMA Cardiol; 2019 Oct; 4(10):1007-1018. PubMed ID: 31433450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnostic value of high-sensitivity cardiac troponin T for cancer treatment-related cardiac dysfunction: a meta-analysis.
    Lv X; Pan C; Guo H; Chang J; Gao X; Wu X; Zhi X; Ren C; Chen Q; Jiang H; Zhao X; Liu K; Li Y
    ESC Heart Fail; 2023 Aug; 10(4):2170-2182. PubMed ID: 37170474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
    Higgins AY; Arbune A; Soufer A; Ragheb E; Kwan JM; Lamy J; Henry M; Cuomo JR; Charifa A; Gallegos C; Hull S; Coviello JS; Bader AS; Peters DC; Huber S; Mojibian HR; Sinusas AJ; Kluger H; Baldassarre LA
    PLoS One; 2021; 16(2):e0246764. PubMed ID: 33606757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early electrocardiographic indices for predicting chronic doxorubicin-induced cardiotoxicity.
    Kinoshita T; Yuzawa H; Natori K; Wada R; Yao S; Yano K; Akitsu K; Koike H; Shinohara M; Fujino T; Shimada H; Ikeda T
    J Cardiol; 2021 Apr; 77(4):388-394. PubMed ID: 33214049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
    Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
    JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction.
    Saijo Y; Kusunose K; Okushi Y; Yamada H; Toba H; Sata M
    Heart; 2020 Nov; 106(22):1752-1758. PubMed ID: 32209616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention.
    Wei SC; Meijers WC; Axelrod ML; Anang NAS; Screever EM; Wescott EC; Johnson DB; Whitley E; Lehmann L; Courand PY; Mancuso JJ; Himmel LE; Lebrun-Vignes B; Wleklinski MJ; Knollmann BC; Srinivasan J; Li Y; Atolagbe OT; Rao X; Zhao Y; Wang J; Ehrlich LIR; Sharma P; Salem JE; Balko JM; Moslehi JJ; Allison JP
    Cancer Discov; 2021 Mar; 11(3):614-625. PubMed ID: 33257470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms.
    Yagi R; Goto S; Himeno Y; Katsumata Y; Hashimoto M; MacRae CA; Deo RC
    Nat Commun; 2024 Mar; 15(1):2536. PubMed ID: 38514629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients.
    Zhou Y; Hou Y; Hussain M; Brown SA; Budd T; Tang WHW; Abraham J; Xu B; Shah C; Moudgil R; Popovic Z; Cho L; Kanj M; Watson C; Griffin B; Chung MK; Kapadia S; Svensson L; Collier P; Cheng F
    J Am Heart Assoc; 2020 Dec; 9(23):e019628. PubMed ID: 33241727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.